CXCR4 and cancer: Additionally, the co-expression of transgenic CXCR4 and anti-BCMA CAR in NK cells was shown to further strengthen their cancer-eradicating effects in a MM xenograft mice model compared to CAR-NK cells without CXCR4 transfection [81].